Neutralizing antibody
Enhanced Neutralizing Antibody Titers and Th1 Polarization from a Novel Escherichia coli Derived Pandemic Influenza Vaccine
11
Boosting subdominant neutralizing antibody responses with a computationally designed epitope-focused immunogen
28
Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01
25
Structural Basis for Broad HIV-1 Neutralization by a Novel MPER-Specific Human Broadly Neutralizing Antibody
25
Dengue Mosaic Vaccines Enhance Cellular Immunity and Expand the Breadth of Neutralizing Antibody Against All Four Serotypes of Dengue Viruses in Mice
11
en fr Study of the neutralizing antibody response against the hepatitis C virus Etude de la réponse humorale neutralisante contre le Virus de l’Hépatite C
253
Circulating CXCR5[superscript +]CXCR3[superscript +]PD-1[superscript lo] Tfh-like cells in HIV-1 controllers with neutralizing antibody breadth
50
IgA dominates the early neutralizing antibody response to SARS-CoV-2
15
HCV entry and neutralizing antibodies: lessons from viral variants.
6
Neutralizing antibodies in hepatitis C virus infection.
26
Antibody-guided vaccine design : identification of protective epitopes
6
Structure of HIV-1 gp41 with its membrane anchors targeted by neutralizing antibodies
27
Antibody evasion by a gammaherpesvirus o-glycan shield.
15
Determining the Phagocytic Activity of Clinical Antibody Samples
6
Antibody-Based Strategies to Prevent and Treat Influenza
7
Assisted design of antibody and protein therapeutics (ADAPT)
18
Antibody drug discovery: From Idea to Biotherapeutic Molecule
91
Single-domain antibody fragments with high conformational stability.
16
Binding symmetry and surface flexibility mediate antibody self-association
21
Ross River Virus Antibody Prevalence, Fiji Islands, 2013–2015
5